This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hangaard, J. Articles by Hagen, C. Search for Related Content PubMed PubMed Citation Articles by Hangaard, J. Articles by Hagen, C.

Pulsatile Luteinizing Hormone Secretion in Patients with Addison’s Disease. Impact of Glucocorticoid Substitution¹

Department of Endocrinology, Odense University Hospital (J.H., M.A., E.G., C.H.), DK-5000 Odense C; and the Department of Clinical Chemistry, Sønderborg Hospital (O.K.), DK-6400 Sønderborg, Denmark

Address all correspondence and requests for reprints to: Jørgen Hangaard, M.D., Department of Endocrinology, Odense University Hospital, DK-5000 Odense C, Denmark.

The physiological and pathophysiological role of cortisol in pulsatile LH release was investigated in 14 patients (5 men, 6 premenopausal women, and 3 postmenopausal women) with Addison’s disease. The explicit effect of cortisol in relation to the effect of corticotropin-releasing factor (CRF), ACTH, and opioids was ensured by hypo-, normo-, and hypercortisolism. Hypocortisolism was obtained by 24-h discontinuation of hydrocortisone (HC) followed by 23-h saline infusion. Eucortisolism was secured by infusion of HC (0.5 mg/kg) over 23 h. Stress-appropriate hypercortisolism was obtained by infusion of HC (2.0 mg/kg) over 23 h, preceded by treatment for 5 days with dexamethasone (1.5 mg/day). To imitate the normal diurnal rhythm for serum cortisol, HC was infused in graduated doses. Blood sampling was performed every 10 min during the last 10 h of the study period, followed by a LH-releasing hormone test (5 µg, iv) and a TRH test (10 µg, iv). In pre- and postmenopausal women, the mean LH level and the LH pulsatility pattern were similar on the 3 occasions. In contrast, the mean LH level in men was significantly reduced during hypocortisolism compared to that during eucortisolism (3.26 ± 0.68 vs. 4.49 ± 0.83 U/L; P < 0.05) and was associated with a clear decrease in LH pulse amplitude (1.09 ± 0.33 vs. 1.96 ± 0.53 U/L; P < 0.05). During high doses of glucocorticoids, the mean LH level in men was significantly lower than that during eucortisolism (3.81 ± 0.88 vs. 4.49 ± 0.83 U/L; P < 0.05). In both men and women, the mean PRL levels increased significantly (P < 0.05) during hypocortisolism, whereas high glucocorticoid doses suppressed the mean PRL level (P < 0.05). The LH and PRL responses to LH-releasing hormone and TRH were, however, similar during low, medium, and high cortisol levels in both men and women. In conclusion, our data suggest that the attenuation of pulsatile LH secretion in men during hypo- and hypercortisolism is due to variations in the hypothalamic opioid activity secondary to alterations in serum cortisol levels. A higher level of opioid receptor activity in men than in low estrogen women may explain the gender differences.

This article has been cited by other articles:

				F. J. Hayes, S. DeCruz, S. B. Seminara, P. A. Boepple, and W. F. Crowley Jr. Differential Regulation of Gonadotropin Secretion by Testosterone in the Human Male: Absence of a Negative Feedback Effect of Testosterone on Follicle-Stimulating Hormone Secretion J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 53 - 58. [Abstract] [Full Text]

				P. Caron, S. Imbeaud, A. Bennet, M. Plantavid, G. Camerino, and P. Rochiccioli Combined Hypothalamic-Pituitary-Gonadal Defect in a Hypogonadic Man with a Novel Mutation in the DAX-1 Gene J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3563 - 3569. [Abstract] [Full Text] [PDF]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen The Effects of Endogenous Opioids and Cortisol on Thyrotropin and Prolactin Secretion in Patients with Addison's Disease J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1595 - 1601. [Abstract] [Full Text]